Immunohistochemical staining intensity of the cell proliferation marker CDC47 showed that TTE- and cisplatin-dependent reduction of tumor volume corresponded with decreased immunohistochemical staining intensity of CDC47 (Figure 5E). This evidence concerns the gene MCM7 and neoplasm.